Pharma Business Line

We co-innovate with global pharmaceutical companies: Syngene MD & CEO

Syngene International, one of the first players in the CRAMS (Custom Research And Manufacturing Services) segment, was spun off from the Indian biotechnology company Biocon to offer contracted R&D capabilities and is now a fully integrated player. When global pharmaceutical majors like Glaxo Smith Kline, Bristol Myers Squibb, Amgen or …

Read More »

Luye Pharma Reports First Results from Phase II Clinical Trial of New Ansofaxin Hydrochloride Extended-Release Antidepressant Tablets

CHONGQING, China, 23 December 2021 / PRNewswire / – Luye Pharma Group today released encouraging first results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005), at 19e Chinese Medical Association National Psychiatry Conference. In general, LY03005 demonstrated overall antidepressant efficacy as well as …

Read More »

Predictive Oncology – Year-end Shareholder Update!

EAGAN, Minnesota, December 21, 2021 (GLOBE NEWSWIRE) – Predictive Oncology, (POAI), a knowledge-driven company focused on the application of artificial intelligence (AI) to develop personalized cancer therapies, is moving in the right direction. In November 2021, POAI acquired zPREDICTA, a leading cancer company with a proven business and scientific record. …

Read More »

Vincerx Pharma Announces Administration of First Patient in Phase 1 Ascending Dose Study of VIP152 for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

PALO ALTO, Calif., December 17, 2021 (GLOBE NEWSWIRE) – Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to meet the unmet medical needs of cancer patients through paradigm shift therapies, announced today that the first patient received a dose in the Company’s Phase 1 dose escalation study of VIP152 …

Read More »

Senate Health Committee once again offers support to FDA Commissioner-designate Rob Califf – Endpoints News

Rob Califf, the famous cardiologist from Duke University, is expected to return to the top of the FDA, this time under the Biden administration. At her confirmation hearing on Tuesday, Democrats and Republicans on the Senate Health Committee offered their support to Califf, with President Patty Murray (D-WA) stressing the …

Read More »

Sensex jumps over 350 points at the start of the trade; Clever tops 17,600

The benchmark Sensex stock index jumped more than 350 points at the start of Monday, following the gains of the major ICICI Bank, HDFC twins and Axis Bank indices amid a positive trend in global markets. The index of 30 stocks jumped 375.30 points or 0.64% to 59,161.97 when trade …

Read More »

The fierce battle for pharmaceutical self-sufficiency – the Island

By Hiran H. Senewiratne Kids & Teens Medical Group, one of the largest and largest pediatric primary care centers in Los Angeles, Calif., With eleven sites and operating successfully for over 15 years, will strengthen its process outsourcing operations commercial or BPO in Sri Lanka. The Kids & Teens Medical …

Read More »

Viatris and Biocon plan to bundle their biosimilars into $ 10 billion stand-alone business – report – Endpoints News

According to sources from Nisha Poddar of an Indian subsidiary of CNBC, Viatris (Mylan / Pfizer’s Upjohn) and India’s Biocon Biologics are debating whether they should further combine their biosimilars business into a stand-alone $ 10 billion business. Earlier this summer, the two companies won the coveted first interchangeability designation …

Read More »

Antares Pharma (NASDAQ: ATRS) Shareholders Gained 10% CAGR in Past Five Years

While Antares Pharma, Inc. (NASDAQ: ATRS) Shareholders are probably generally happy, the stock hasn’t gone particularly well recently, with the stock price falling 13% in the last quarter. On the positive side, the stock price has risen over the past five years. Meanwhile, it’s up 64%, which isn’t bad, but …

Read More »